This page is part of Gloshell’s Coupang Partners activity, and Gloshell receives a set commission on purchases made through it.
What the ingredients say
Read from the label order, stated amounts and each ingredient’s clinical evidence
Niacinamide, with clinical evidence for dark spots·skin barrier, is in at the MFDS notified amount for brightening (2–5%).
Adenosine, with clinical evidence for lines, is in at the MFDS notified amount for wrinkle care (0.04%).
Dipeptide-15, which the product is named after, is present at only 0.01%.
SH-Oligopeptide-1, which the product is named after, is present at only 0.00000002%.
- no fragrance
MFDS functional cosmetic filing
Filed with Korea's MFDS as a brightening·wrinkle care functional cosmetic (2025-08). Its efficacy ingredient and amount are those the MFDS notice names.
Best-supported ingredient per concern
- Dark spotsNiacinamideevidence BMFDS brightening amount
- Skin barrierNiacinamideevidence B-MFDS brightening amount
- OilinessNiacinamideevidence B-MFDS brightening amount
- BlemishesNiacinamideevidence B-MFDS brightening amount
- LinesAdenosineevidence B-MFDS wrinkle care amount
- DrynessGlycerinevidence B+likely enough
Evidence-graded ingredients and how much is in
Filed with Korea's MFDS as a brightening functional cosmetic, so it holds the notified amount (2–5%).
Dark spots B · Oiliness B- · Skin barrier B- · Blemishes B- · Pores C · Lines C
Filed with Korea's MFDS as a wrinkle care functional cosmetic, so it holds the notified amount (0.04%).
Lines B-
No amount is stated. Judging by products that state an evidence-graded ingredient at this place on the label, the chance it reaches the amount studies used is about 68%.
Dryness B+ · Skin barrier B
No amount is stated. Judging by 85 products that state it at this place on the label, the chance it reaches the amount studies used is about 11%.
Skin barrier B+ · Dryness C
No amount is stated. Judging by 175 products that state it at this place on the label, the chance it reaches the amount studies used is about 12%.
Dryness B · Lines D
2 more evidence-graded ingredients
No amount is stated. Judging by products that state an evidence-graded ingredient at this place on the label, the chance it reaches the amount studies used is about 5%.
Dryness C
No amount is stated. Judging by products that state an evidence-graded ingredient at this place on the label, the chance it reaches the amount studies used is about 5%.
Skin barrier D
Amounts on the label
- Serica0.05%trace (under 0.1%)
- Dipeptide-15in the name0.01%trace (under 0.1%)
- SH-Oligopeptide-1in the name0.00000002%trace (under 0.1%)
- SH-Oligopeptide-2in the name0.00000002%trace (under 0.1%)
- SH-Polypeptide-1in the name0.00000002%trace (under 0.1%)
- SH-Polypeptide-3in the name0.00000002%trace (under 0.1%)
- SH-Polypeptide-16in the name0.00000001%trace (under 0.1%)
- SH-Polypeptide-22in the name0.00000001%trace (under 0.1%)
- SH-Polypeptide-60in the name0.00000001%trace (under 0.1%)
- SH-Polypeptide-62in the name0.00000001%trace (under 0.1%)
- SH-Polypeptide-9in the name0.00000001%trace (under 0.1%)
- Palmitoyl Tetrapeptide-7in the name0.00000001%trace (under 0.1%)
- Palmitoyl Tripeptide-1in the name0.00000001%trace (under 0.1%)
Korean law requires a product to state the amount of any ingredient in its name.
How this was read
Labels list ingredients above 1% from most to least, then those at 1% or less in any order. A product filed with Korea's MFDS as functional is read as holding the notified amount of its efficacy ingredient when the label carries only one for that effect, and anything listed before an ingredient of known amount as holding at least that much. Amounts in the product name or official description are used only where the label order allows them. Where no amount is stated, the chance of reaching the study amount comes from other products that state the same ingredient at the same place on their labels. Evidence grades were set by reading each ingredient's studies.
- A
- several randomised trials or a meta-analysis
- B
- one or two randomised trials
- C
- uncontrolled or multi-ingredient studies
- D
- lab work or a record only
A reading of ingredient evidence and the label, not a guarantee that this product works.
Ingredients
Full ingredient list as published on the official product page, in descending order of content.
All 47 ingredients at a glance
Colours follow each ingredient’s use (CosIng functions); the bar counts names. Not amounts, not a safety score.
Aqua, Butylene Glycol, Glycerin, Methylpropanediol, Niacinamide, Benzyl Glycol, C12-14 Alketh-3, Estimated 1% or less from hereCarbomer, Tromethamine, Betaine, Allantoin, Hydroxyethylcellulose, Ethylhexylglycerin, Serica500ppm, 1,2-Hexanediol, Adenosine, Disodium Edta, Hydrolyzed Collagen, Dipeptide-15100ppm, Panthenol, CI 77891, Mica, Agar, Gellan GUM, Calcium Alginate, Caprylyl Glycol, Chondrus Crispus Extract, CI 77491, Sodium Hyaluronate, Squalane, Propanediol, Hydrolyzed Elastin, Gold, Disodium Phosphate, Polysorbate 60, Sodium Phosphate, SH-Oligopeptide-10.0002ppm, SH-Oligopeptide-20.0002ppm, SH-Polypeptide-10.0002ppm, SH-Polypeptide-30.0002ppm, SH-Polypeptide-160.0001ppm, SH-Polypeptide-220.0001ppm, SH-Polypeptide-600.0001ppm, SH-Polypeptide-620.0001ppm, SH-Polypeptide-90.0001ppm, Palmitoyl Tetrapeptide-70.0001ppm, Palmitoyl Tripeptide-10.0001ppm
Tap a name to see what it does and the evidence
How to use
Directions and cautions found on the package or public product information.
- Directions
- 1. 앰플 상단의 투명한 캡을 제거해 줍니다. 2. 주사기 캡을 분리한 뒤, 앰플 상단 중앙 홈에 밀어 넣어 끼워줍니다. 3. 앰플을 뒤집듯 기울인 상태에서 주사기의 피스톤을 당겨 적당량을 채운 뒤, 피부에 도포해 줍니다.
Product details
- Manufacturer
- (주)한국씨엔비
- Country of manufacture
- 대한민국
- Responsible distributor
- (주)와이즐리컴퍼니